Avanos Medical (AVNS) Operating Leases (2019 - 2026)

Avanos Medical has disclosed Operating Leases across 8 years of filings, most recently posting $29.8 million for Q1 2026.

• In Q1 2026, Operating Leases rose 29.0% year-over-year to $29.8 million; the TTM figure through Mar 2026 stood at $29.8 million (up 29.0% YoY), while the FY2025 annual figure was $20.4 million, down 42.54% from the prior year.
• Operating Leases came in at $29.8 million for Q1 2026 at Avanos Medical, up from $20.4 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $44.5 million in Q4 2022 to a low of $20.4 million in Q4 2025.
• Average Operating Leases over 5 years is $31.0 million, with a median of $29.8 million recorded in 2026.
• Year-over-year, Operating Leases tumbled 42.54% in 2025 and gained 29.0% in 2026.
• Over 5 years, Operating Leases stood at $44.5 million in 2022, then fell by 7.64% to $41.1 million in 2023, then fell by 13.63% to $35.5 million in 2024, then plunged by 42.54% to $20.4 million in 2025, then jumped by 46.08% to $29.8 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $29.8 million in Q1 2026, $20.4 million in Q4 2025, and $21.4 million in Q3 2025.